MedTrace Logo

MOCHA Moving Forward: a CBPR Investigation of Chronic Disease Prevention in Older, Low-income African-American Men

NCT03745703 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 261

Last updated 2022-11-08

No results posted yet for this study

Summary

The overall goal of the research is to discover how to reduce chronic disease health disparities among older (ages 35-70) low-income African-American men more effectively. To achieve this goal, the investigators are conducting formative exploratory research with middle-aged, low-income African-American men; testing two versions of a novel community-developed intervention, MOCHA and MOCHA+ (where MOCHA+ is a modified version of the "standard" MOCHA program, modified to incorporate narrative communication strategies); and advancing the development of a Minority Stress Model through statistical modelling to test the relative contributions of hypothesized explanatory variables identified in the formative research phase of the project.

Conditions

  • Chronic Disease of Cardiovascular System
  • Multiple Chronic Conditions
  • Chronic Disease

Interventions

BEHAVIORAL

MOCHA

(see above)

Sponsors & Collaborators

  • University of Massachusetts, Worcester

    collaborator OTHER

  • YMCA

    collaborator OTHER

  • University of Massachusetts, Amherst

    lead OTHER

Principal Investigators

  • David Buchanan, DrPH · UMass School of Public Health & Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-03
Primary Completion
2021-07-31
Completion
2021-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03745703 on ClinicalTrials.gov